West Pharmaceutical(WST) - 2025 Q2 - Quarterly Results

Exhibit 99.1 West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance - Conference Call Scheduled for 8 a.m. EDT Today - Eric M. Green, President, Chief Executive Officer and Chair of the Board, commented: "I am pleased to report that we exceeded our expectations for the second quarter driven by solid growth in HVP components. This was the result of strong GLP-1 elastomer growth, ongoing momentum in HVP conversion mainly related to Annex 1 projects and the ...